Marshall Joffe’s Contributions to Causal Inference, Biostatistics, and Epidemiology
- 7 November 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 193 (4) , 563-576
Abstract
We pay tribute to Marshall Joffe, PhD, and his substantial contributions to the field of causal inference with focus in biostatistics and epidemiology. By compiling narratives written by us, his colleagues, we not only present highlights of Marshall’s research and their significance for causal inference but also offer a portrayal of Marshall’s personal accomplishments and character. Our discussion of Marshall’s research notably includes (but is not limited to) handling of post-treatment variables such as noncompliance, employing G-estimation for treatment effects on failure-time outcomes, estimating effects of time-varying exposures subject to time-varying confounding, and developing a causal framework for case-control studies. We also provide a description of some of Marshall’s unpublished work, which is accompanied by a bonus anecdote. We discuss future research directions related to Marshall’s research. While Marshall’s impact in causal inference and the world outside of it cannot be wholly captured by our words, we hope nonetheless to present some of what he has done for our field and what he has meant to us and to his loved ones.Keywords
This publication has 39 references indexed in Scilit:
- A Note on Posttreatment Selection in Studying Racial Discrimination in PolicingAmerican Political Science Review, 2021
- Blood pressure and the risk of chronic kidney disease progression using multistate marginal structural models in the CRIC StudyStatistics in Medicine, 2017
- Tom Ten Have's contributions to causal inference and biostatistics: review and future research directionsStatistics in Medicine, 2012
- Subtle issues in model specification and estimation of marginal structural modelsPharmacoepidemiology and Drug Safety, 2012
- Double‐robust estimation of an exposure‐outcome odds ratio adjusting for confounding in cohort and case‐control studiesStatistics in Medicine, 2010
- Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patientsJournal of Clinical Epidemiology, 2004
- Weighting in instrumental variables and G‐estimationStatistics in Medicine, 2003
- Confounding by indication: the case of calcium channel blockersPharmacoepidemiology and Drug Safety, 2000
- The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and EpoetinNew England Journal of Medicine, 1998
- A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effectMathematical Modelling, 1986